Tuesday 10 January 2023
07:45
Kate Bingham and Tim Hames
The Inside Story of the Race to Vaccinate Britain
Kate’s razor-sharp focus on outcomes rather than on following procedures ensured availability of Covid-19 vaccines. This was despite the political manoeuvring, miscommunications and administrative meddling that nearly jeopardised the project.
Kate served as the Chair of the UK Vaccine Taskforce, on a seven-month unpaid secondment, steering a team of experts to deliver the world’s fastest Covid-19 vaccination programme. She is Managing Partner at life sciences venture capital firm SV Health Investors where she co-leads SV’s biotech franchise which has a long history of developing transformational new medicines. She is a board member of the Francis Crick Institute and was awarded a DBE in the Queen’s Birthday Honours for her services as Chair of the UK Vaccine Taskforce.
Tim started his career as an academic. He was a Lecturer in Politics at Oxford University from 1989–1996 specialising in American and British Government. He then moved to The Times where he became the chief editorial writer, a weekly columnist and regularly edited the newspaper as a whole. In 2009 he joined the British Private Equity and Venture Capital Association (BVCA) as Head of Communications and Public Affairs and served as Director General of that organisation from 2013–2019. He is now an independent writer, consultant and senior adviser
'Bingham delivers on her punchy promise in the prologue to "tell it like it is". As an outsider rooted in business, she offers strong and specific recommendations for transforming government. Most deliciously, she names.'
Former Chair of the UK Vaccine Taskforce and Managing Partner at SV Health Investors; Consultant and Senior Advisor
Kate served as the Chair of the UK Vaccine Taskforce, on a seven-month unpaid secondment, steering a team of experts to deliver the world’s fastest Covid-19 vaccination programme. She is Managing Partner at life sciences venture capital firm SV Health Investors where she co-leads SV’s biotech franchise which has a long history of developing transformational new medicines. She is a board member of the Francis Crick Institute and was awarded a DBE in the Queen’s Birthday Honours for her services as Chair of the UK Vaccine Taskforce.
Tim started his career as an academic. He was a Lecturer in Politics at Oxford University from 1989–1996 specialising in American and British Government. He then moved to The Times where he became the chief editorial writer, a weekly columnist and regularly edited the newspaper as a whole. In 2009 he joined the British Private Equity and Venture Capital Association (BVCA) as Head of Communications and Public Affairs and served as Director General of that organisation from 2013–2019. He is now an independent writer, consultant and senior adviser
